Results 191 to 200 of about 4,747,249 (340)

Mucosomes as next-generation drug carriers for treating mucus-resident bacterial infections and biofilms. [PDF]

Sci Rep
Guagliano G, Peluso E, Butnarasu CS, Restivo E, Sardelli L, Frasca E, Petrini P, Tirelli N, Sganga S, Visai L, Visentin S.   +10 more
europepmc   +1 more source

Retracted: A Critical Scrutiny on Liposomal Nanoparticles Drug Carriers as Modelled by Topotecan Encapsulation and Release in Treating Cancer. [PDF]

Evid Based Complement Alternat Med, 2023
And Alternative Medicine EC.
europepmc   +1 more source

Semitelechelic HPMA Copolymers Functionalized with Triphenylphosphonium as Drug Carriers for Membrane Transduction and Mitochondrial Localization [PDF]

, 2006
Jon Callahan, Jindřich Kopeček
openalex   +1 more source

CSF Biomarker‐Based Cognitive Trajectories in Parkinson's Disease‐Subjective Cognitive Decline

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Cognitive complaints without objective cognitive impairment in Parkinson's Disease, termed Parkinson's Disease‐Subjective Cognitive Decline (PD‐SCD), have been associated with cognitive decline. However, its progression is heterogeneous, highlighting the need for improved identification of patients at greater risk for deterioration ...
Jon Rodriguez‐Antiguedad, Arnau Puig‐Davi, Iñigo Ruíz‐Barrio, Javier Pagonabarraga, Anna Vázquez‐Oliver, Andrea Horta‐Barba, Jaime Kulisevsky, Saül Martínez‐Horta   +7 more
wiley   +1 more source

The Frontiers of Drug Carrier

YAKUGAKU ZASSHI, 2007
openaire   +2 more sources

Revolutionizing Retinal Therapy: The Role of Nanoparticle Drug Carriers in Managing Vascular Retinal Disorders. [PDF]

Clin Ophthalmol
Lu H, He N, Zhang L, You Y, Lv Z.
europepmc   +1 more source

Contemporary Aspects of Designing Marine Polysaccharide Microparticles as Drug Carriers for Biomedical Application. [PDF]

Pharmaceutics, 2023
Lukova P, Katsarov P.
europepmc   +1 more source

Amphiphilic star-like macromolecules as novel carriers for topical delivery of nonsteroidal anti-inflammatory drugs

, 2003
Jelena Djordjević, Bozena Michniak, Kathryn E. Uhrich   +2 more
openalex   +2 more sources

SARS‐CoV‐2 Is Linked to Brain Volume Loss in Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective The impact of SARS‐CoV‐2 infection on brain and spinal cord pathology in patients with multiple sclerosis (pwMS) remains unclear. We aimed to describe changes in brain lesion activity and brain and spinal cord volumes following SARS‐CoV‐2 infection.
Tomas Uher, Dominika Stastna, Ingrid Menkyova, Vaclav Capek, Jiri Lindner, Petra Nytrova, Jan Krasensky, Eliza Varju, Miguel D'haeseleer, Eva Kubala Havrdova, Dana Horakova, Manuela Vaneckova, Niels Bergsland   +12 more
wiley   +1 more source

Editorial: Driving extracellular vesicles toward applications in precision medicine

Frontiers in Medicine, 2022
Somchai Chutipongtanate, Somchai Chutipongtanate, Somchai Chutipongtanate, Somchai Chutipongtanate, Kovit Pattanapanyasat, Jarek Meller, Jarek Meller, Jarek Meller, Juana Serrano López   +8 more
doaj   +1 more source